SecBot SecBot

HSPTR

Horizon Space Acquisition II Corp.
Nasdaq· Blank Checks· Inc. E9· CIK 0002032950 Traditional Finance
Rights of Horizon Space Acquisition II Corp. · HSPT stock page →
—
Short interest
3.3K
−18.9%
Days to cover
1.0
at average volume
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest NEUTRAL Horizon Space Acquisition II Corp. extended its deadline to complete a business combination by one month…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • Short sellersCOVERING

    Short interest −18.9% to 3.3K shares. 1.0 days to cover.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
May 28, 2026
FDA
Krystexxa
WARNING: ANAPHYLAXIS and INFUSION REACTIONS, G6PD DEFICIENCY ASSOCIATED HEMOLYSIS and METHEMOGLOBINEMIA Anaphylaxis and infusion reactions have been r
Mar 24, 2026
Clinical Trial
Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-Aging
Phase 2 · COMPLETED

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current FY———$0.00
Next FY———$0.00
Next Q———$0.00
Current Q———$0.00

Short side

FINRA· May 29, 2026
3,289
shares short
-18.9%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 28, 2026 Event
Krystexxa
WARNING: ANAPHYLAXIS and INFUSION REACTIONS, G6PD DEFICIENCY ASSOCIATED HEMOLYSIS and METHEMOGLOBINE
Apr 21, 2026 SEC
Horizon Space Acquisition II Corp. extended its deadline to complete a business combination by one month through a…
8-K — Impact 3/10

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All HSPTR filing & press-release reports (1)